Unknown

Dataset Information

0

Inhibition of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) stimulates osteoblastogenesis by potentiating bone morphogenetic protein 2 (BMP2) responses.


ABSTRACT: The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is a pleiotropic enzyme involved in DNA repair, cell cycle control, and transcription regulation. A potential role for DNA-PKcs in the regulation of osteoblastogenesis remains to be established. We show that pharmacological inhibition of DNA-PKcs kinase activity or gene silencing of Prkdc (encoding DNA-PKcs) in murine osteoblastic MC3T3-E1 cells and human adipose-derived mesenchymal stromal cells markedly enhanced osteogenesis and the expression of osteoblast differentiation marker genes. Inhibition of DNA-PKcs inhibited cell cycle progression and increased osteogenesis by significantly enhancing the bone morphogenetic protein 2 response in osteoblasts and other mesenchymal cell types. Importantly, in vivo pharmacological inhibition of the kinase enhanced bone biomechanical properties. Bones from osteoblast-specific conditional Prkdc-knockout mice exhibited a similar phenotype of increased stiffness. In conclusion, DNA-PKcs negatively regulates osteoblast differentiation, and therefore DNA-PKcs inhibitors may have therapeutic potential for bone regeneration and metabolic bone diseases.

SUBMITTER: Farhat T 

PROVIDER: S-EPMC7680411 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5568904 | biostudies-literature
| S-EPMC3515620 | biostudies-other
| S-EPMC4069685 | biostudies-literature
| S-EPMC547837 | biostudies-other
| S-EPMC3922905 | biostudies-other
2019-12-10 | GSE141686 | GEO
2020-05-28 | GSE151332 | GEO
| S-EPMC4913784 | biostudies-literature
| S-EPMC4862620 | biostudies-literature
2019-12-10 | PXD016595 | Pride